Recombinant human erythropoietin alpha in the correction of anaemia in epidermolysis bullosa.
Antunes
I
I
Resende
C
C
Granjo
E
E
Mesquita-Guimãres
J
J
D000328:Adult; D000740:Anemia / Q000188:drug therapy* / Q000209:etiology; D001803:Blood Transfusion; D002908:Chronic Disease; D003692:Delayed-Action Preparations; D016108:Epidermolysis Bullosa Dystrophica / Q000150:complications*; D004921:Erythropoietin / Q000627:therapeutic use*; D005260:Female; D005296:Ferrous Compounds / Q000627:therapeutic use; D005492:Folic Acid / Q000627:therapeutic use; D006397:Hematinics / Q000627:therapeutic use; D006801:Humans; D011994:Recombinant Proteins
D003692:Delayed-Action Preparations; D005296:Ferrous Compounds; D006397:Hematinics; D011994:Recombinant Proteins; D004921:Erythropoietin; C020748:ferrous sulfate; D005492:Folic Acid